Salix contacts Actavis over potential sale-source

NEW YORK, Sept 24 (Reuters) - Salix Pharmaceuticals Ltd has had contact with Actavis Plc about a potential sale to the larger drugmaker, as it continues discussions with Allergan Inc about selling itself, according to a person familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.